• 1
    Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339350.
  • 2
    Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467484.
  • 3
    Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care 1996; 19: 278286.
  • 4
    Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohydrate intolerance of cirrhosis. J Clin Endocrinol Metab 1980; 51: 10301036.
  • 5
    Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 1998; 274: E692E699.
  • 6
    Tripathy D, Almgren P, Tuomi T, Groop L. Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 2004; 27: 22042210.
  • 7
    Chen H, Sullivan G, Yue LQ, Katz A, Quon MJ. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab 2003; 284: E804E812.
  • 8
    Beard JC, Bergman RN, Ward WK, Porte D Jr. The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes 1986; 35: 362369.
  • 9
    Hosker JP, Matthews DR, Rudenski AS et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia 1985; 28: 401411.
  • 10
    Cheng C, Campbell KL, Kushner H, Falkner BE. Correlation of oral glucose tolerance test-derived estimates of insulin sensitivity with insulin clamp measurements in an African-American cohort. Metabolism 2004; 53: 11071112.
  • 11
    Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981; 30: 387392.
  • 12
    Mizrahi M, Lalazar G, Adar T, Raz I, Ilan Y. Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J 2010; 9: 25.
  • 13
    Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009; 33(Suppl. 1): S33S40.
  • 14
    Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004; 53: 27352740.
  • 15
    Banerji MA, Lebowitz J, Chaiken RL, Gordon D, Kral JG, Lebovitz HE. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 1997; 273: E425E432.
  • 16
    Gumbs AA, Modlin IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15: 462473.
  • 17
    Gabriely I, Ma XH, Yang XM et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002; 51: 29512958.
  • 18
    Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 2005; 22: 674682.
  • 19
    Tschoner A, Sturm W, Engl J et al. Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery. Nutr Metab Cardiovasc Dis 2010; doi:10.1016/j.numecd.2010.07.009.
  • 20
    Tschoner A, Sturm W, Engl J et al. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) 2008; 16: 24392444.
  • 21
    Pontiroli AE, Pizzocri P, Librenti MC et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002; 87: 35553561.
  • 22
    Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 17931801.
  • 23
    Rytka JM, Wueest S, Schoenle EJ, Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes 2011; 60: 5663.
  • 24
    Barbuio R, Milanski M, Bertolo MB, Saad MJ, Velloso LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 2007; 194: 539550.
  • 25
    Bruun JM, Stallknecht B, Helge JW, Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007; 157: 465471.
  • 26
    Vazquez LA, Pazos F, Berrazueta JR et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90: 316322.
  • 27
    Moschen AR, Molnar C, Geiger S et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 2010; 59: 12591264.
  • 28
    Pallayova M, Steele KE, Magnuson TH et al. Sleep apnea determines soluble TNF-alpha receptor 2 response to massive weight loss. Obes Surg 2011; 21: 14211423.
  • 29
    Abbasi F, Chu JW, Lamendola C et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53: 585590.
  • 30
    Stefan N, Stumvoll M, Vozarova B et al. Plasma adiponectin and endogenous glucose production in humans. Diabetes Care 2003; 26: 33153319.
  • 31
    Bullo M, Salas-Salvado J, Garcia-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes Surg 2005; 15: 382386.
  • 32
    Benedix F, Westphal S, Patschke R et al. Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011; 21: 616624.
  • 33
    Zimmet PZ, Collins VR, De Court MP et al. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group. Int J Obes Relat Metab Disord 1998; 22: 171177.
  • 34
    Szanto I, Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci U S A 2000; 97: 23552360.
  • 35
    Benomar Y, Wetzler S, Larue-Achagiotis C, Djiane J, Tome D, Taouis M. In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus. Mol Cell Endocrinol 2005; 242: 5966.
  • 36
    Rossetti L, Massillon D, Barzilai N et al. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem 1997; 272: 2775827763.
  • 37
    Kennedy A, Gettys TW, Watson P et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 12931300.
  • 38
    Finucane FM, Luan J, Wareham NJ et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009; 52: 23452349.
  • 39
    Robles-Cervantes JA, Martinez-Abundis E, Gonzalez-Ortiz M, Cardenas-Camarena L, Hernandez-Salazar E, Olvera-Ozuna R. Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up. Obes Surg 2007; 17: 12421247.
  • 40
    Mittendorfer B, Horowitz JF, Depaoli AM, McCamish MA, Patterson BW, Klein S. Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes. Diabetes 2011; 60: 14741477.
  • 41
    Schwartz MW, Baskin DG, Bukowski TR et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45: 531535.
  • 42
    Faraj M, Havel PJ, Phelis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 15941602.
  • 43
    Heilbronn LK, Rood J, Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004; 89: 18441848.
  • 44
    Pfutzner A, Langenfeld M, Kunt T, Lobig M, Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003; 49: 571576.
  • 45
    Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331335.
  • 46
    de Luis DA, Terroba MC, Cuellar L et al. Resistin levels in morbid obese patients following the biliopancreatic diversion surgery. Horm Metab Res 2011; 43: 205208.
  • 47
    Edwards C, Hindle AK, Fu S, Brody F. Downregulation of leptin and resistin expression in blood following bariatric surgery. Surg Endosc 2010; 6: 19621968.
  • 48
    Jankiewicz-Wika J, Kolomecki K, Cywinski J et al. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol Pol 2011; 62: 109119.
  • 49
    Nijhuis J, van Dielen FM, Fouraschen SM et al. Endothelial activation markers and their key regulators after restrictive bariatric surgery. Obesity (Silver Spring) 2007; 15: 13951399.
  • 50
    Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426430.
  • 51
    Swarbrick MM, Stanhope KL, Austrheim-Smith IT et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008; 51: 19011911.
  • 52
    Botella-Carretero JI, Luque-Ramirez M, Alvarez-Blasco F, Peromingo R, San Millan JL, Escobar-Morreale HF. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg 2008; 18: 10001006.
  • 53
    Broch M, Gomez JM, Auguet MT et al. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg 2010; 20: 12581264.
  • 54
    Haider DG, Schindler K, Prager G et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007; 92: 11681171.
  • 55
    Kelly KR, Kashyap SR, O'Leary VB, Major J, Schauer PR, Kirwan JP. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity (Silver Spring) 2010; 18: 663666.
  • 56
    Mitterberger MC, Mattesich M, Klaver E et al. Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. J Gerontol A Biol Sci Med Sci 2010; 65: 915923.
  • 57
    Hartmann H, Ebert R, Creutzfeldt W. Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver. Diabetologia 1986; 29: 112114.
  • 58
    Rao RS, Kini S. GIP and bariatric surgery. Obes Surg 2011; 21: 244252.
  • 59
    Larsson H, Holst JJ, Ahren B. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. Acta Physiol Scand 1997; 160: 413422.
  • 60
    Orskov L, Holst JJ, Moller J et al. GLP-1 does not acutely affect insulin sensitivity in healthy man. Diabetologia 1996; 39: 12271232.
  • 61
    Perreault L, Man CD, Hunerdosse DM, Cobelli C, Bergman BC. Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose. Diabetes Res Clin Pract 2010; 90: 8794.
  • 62
    Harder H, Nielsen L, Tu DT, Astrup A. The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. Diabetes Care 2004; 27: 19151921.
  • 63
    Campos GM, Rabl C, Peeva S et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14: 1523.
  • 64
    Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 1996; 137: 29682978.
  • 65
    Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 16231630.
  • 66
    Harvey EJ, Arroyo K, Korner J, Inabnet WB. Hormone changes affecting energy homeostasis after metabolic surgery. Mt Sinai J Med 2010; 77: 446465.
  • 67
    Vestergaard ET, Gormsen LC, Jessen N et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008; 57: 32053210.
  • 68
    Vestergaard ET, Buhl M, Gjedsted J et al. Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. J Clin Endocrinol Metab 2011; 96: 468477.
  • 69
    Stanhope KL, Schwarz JM, Keim NL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 13221334.
  • 70
    Lau C, Faerch K, Glumer C et al. Dietary glycemic index, glycemic load, fiber, simple sugars, and insulin resistance: the Inter99 study. Diabetes Care 2005; 28: 13971403.
  • 71
    Bikman BT, Zheng D, Pories WJ et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab 2008; 93: 46564663.
  • 72
    Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA. Effect of weight loss on muscle lipid content in morbidly obese subjects. Am J Physiol Endocrinol Metab 2003; 284: E726E732.
  • 73
    Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg 2006; 16: 11791188.
  • 74
    Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 111.
  • 75
    Higgins J. 2011. Cochrane handbook for systematic reviews of interventions. [WWW document]. URL (accessed September 2011).
  • 76
    Kashyap SR, Daud S, Kelly KR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010; 34: 462471.
  • 77
    Pontiroli AE, Gniuli D, Mingrone G. Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg 2010; 20: 474479.
  • 78
    Umeda LM, Silva EA, Carneiro G, Arasaki CH, Geloneze B, Zanella MT. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients. Obes Surg 2011; 21: 896901.
  • 79
    Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy–a prospective randomized trial. Surg Obes Relat Dis 2011; 7: 561568.
  • 80
    Garrido-Sanchez L, Murri M, Rivas-Becerra J et al. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg Obes Relat Dis 2011; doi:10.1016/j.soard.2011.03.010.
  • 81
    Korner J, Inabnet W, Febres G et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009; 33: 786795.
  • 82
    Rizzello M, Abbatini F, Casella G et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 2010; 20: 5055.
  • 83
    Jorgensen NB, Jacobsen SH, Worm D et al. Doubling of both insulin sensitivity and beta cell function explains remission of type 2 diabetes within one week after Roux-en-Y gastric bypass. Diabetologia 2010; 53: S268.
  • 84
    Gavish D, Leibo L, Leibovitz E, Shachter P, Wainstein J, Shimonov M. Immediate reduction of glucose and insulin levels and improvement of insulin resistance among non-diabetic morbidly obese people undergoing gastric sleeve operation for weight reduction. Diabetes 2011; 3: 62.
  • 85
    Hansen EN, Tamboli RA, Isbell JM et al. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 2011; 300: G795G802.
  • 86
    Adami GF, Parodi RC, Papadia F et al. Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. Obes Surg 2005; 15: 12331237.
  • 87
    Briatore L, Salani B, Andraghetti G et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring) 2008; 16: 7781.
  • 88
    Briatore L, Salani B, Andraghetti G et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity (Silver Spring) 2010; 18: 932936.
  • 89
    Konukoglu D, Uzun H, Firtina S, Cigdem AP, Kocael A, Taskin M. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 2007; 17: 672678.
  • 90
    Lin E, Davis SS, Srinivasan J et al. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg 2009; 75: 498502.
  • 91
    Salani B, Briatore L, Andraghetti G, Adami GF, Maggi D, Cordera R. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity (Silver Spring) 2006; 14: 15111514.
  • 92
    Belgaumkar AP, Vincent RP, Carswell KA et al. Bile acid absorption does not change after laparoscopic sleeve gastrectomy. Obes Res 2011; 21: 1106.
  • 93
    Ciccarone A, Pulizzi N, Uccii A et al. First phase insulin secretion restoration in T2DM subjects 1 month after Roux-en-Y gastric bypass. Obes Rev 2011; 11: 257258.
  • 94
    Brethauer SA, Heneghan HM, Eldar S et al. Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc 2011; 25: 26502659.
  • 95
    Heath ML, Kow L, Slavotinek JP, Valentine R, Toouli J, Thompson CH. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism 2009; 58: 753758.
  • 96
    Mutch DM, Fuhrmann JC, Rein D et al. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One 2009; 4: e7905.
  • 97
    Phillips ML, Boase S, Wahlroos S et al. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery. Diabetes Obes Metab 2008; 10: 661667.
  • 98
    Trakhtenbroit MA, Leichman JG, Algahim MF et al. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med 2009; 122: 435442.
  • 99
    Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 2010; 95: 28452850.
  • 100
    Carroll JF, Franks SF, Smith AB, Phelps DR. Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study. Obes Surg 2009; 19: 4755.
  • 101
    Garrapa GG, Canibus P, Gatti C et al. Changes in body composition and insulin sensitivity in severely obese subjects after laparoscopic adjustable silicone gastric banding (LASGB). Med Sci Monit 2005; 11: CR522CR528.
  • 102
    Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006; 91: 15781581.
  • 103
    Hanusch-Enserer U, Ghatei MA, Cauza E, Bloom SR, Prager R, Roden M. Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery. Wien Klin Wochenschr 2007; 119: 291296.
  • 104
    Iannelli A, Anty R, Schneck AS, Tran A, Gugenheim J. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery 2011; 149: 364370.
  • 105
    Mancini A, Leone E, Festa R et al. Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion. Metabolism 2008; 57: 13841389.
  • 106
    Moschen AR, Molnar C, Wolf AM et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 2009; 51: 765777.
  • 107
    Sesti G, Perego L, Cardellini M et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 2005; 90: 50645069.
  • 108
    Uzun H, Konukoglu D, Gelisgen R, Zengin K, Taskin M. Plasma protein carbonyl and thiol stress before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 2007; 17: 13671373.
  • 109
    Wahlroos S, Phillips ML, Lewis MC et al. Rapid significant weight loss and regional lipid deposition: implications for insulin sensitivity. Obes Res Clin Pract 2007; 1: 716.
  • 110
    Schuster DP, Teodorescu M, Foreman K, Mikami D, Needleman BJ. Resumption of diabetes medications with changes in eating patterns after the immediate post-operative period following Roux-en-Y gastric bypass. Obes Res 2011; 21: 983984.
  • 111
    Nosso G, Angrisani L, Saldalamacchia G et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes 2011; 2011: 340867.
  • 112
    Gazzaruso C, Giordanetti S, La MA et al. Weight loss after Swedish adjustable gastric banding: relationships to insulin resistance and metabolic syndrome. Obes Surg 2002; 12: 841845.
  • 113
    Frige F, Laneri M, Veronelli A et al. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 2009; 19: 198204.
  • 114
    Lubrano C, Mariani S, Badiali M et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes (Lond) 2010; 34: 14041414.
  • 115
    Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 2004; 28: 671673.
  • 116
    De ML, Bianchi A, Mancini A et al. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition. J Clin Endocrinol Metab 2004; 89: 174180.
  • 117
    Gniuli D, Rosa G, Manco M et al. Changes in fat mass influence SREBP-1c and UCP-2 gene expression in formerly obese subjects. Obes Res 2005; 13: 567573.
  • 118
    Lee H, Kim D, Lee S, Nam K, Kim E. Initial evaluation of laparoscopic Roux-en-Y gastric bypass and adjustable gastric banding in Korea: a single institution study. Obes Surg 2010; 20: 10961101.
  • 119
    Lee WJ, Lee YC, Ser KH, Chen JC, Chen SC. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 2008; 18: 11191125.
  • 120
    Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 2010; 20: 308315.
  • 121
    Ballantyne GH, Farkas D, Laker S, Wasielewski A. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg 2006; 16: 11891197.
  • 122
    Manco M, Fernandez-Real JM, Valera-Mora ME et al. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon? Diabetes Care 2007; 30: 14941500.
  • 123
    Mingrone G, Manco M, Iaconelli A et al. Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery. Obesity (Silver Spring) 2008; 16: 18311837.
  • 124
    Valera-Mora ME, Simeoni B, Gagliardi L et al. Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr 2005; 81: 12921297.
  • 125
    Manco M, Calvani M, Nanni G et al. Low 25-hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery. Obes Res 2005; 13: 16921700.
  • 126
    Mari A, Manco M, Guidone C et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006; 49: 21362143.
  • 127
    Mingrone G, Nolfe G, Gissey GC et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia 2009; 52: 873881.
  • 128
    Camastra S, Gastaldelli A, Mari A et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011; 54: 20932102.
  • 129
    Peterli R, Wolnerhanssen B, Peters T et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234241.
  • 130
    Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 12871293.
  • 131
    Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 2011; 93: 10481052.
  • 132
    Viljanen AP, Iozzo P, Borra R et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metab 2009; 94: 5055.
  • 133
    Isbell JM, Tamboli RA, Hansen EN et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 14381442.
  • 134
    Pournaras DJ, Osborne A, Hawkins SC et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010; 252: 966971.
  • 135
    Guidone C, Manco M, Valera-Mora E et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 20252031.
  • 136
    Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O. Insulin resistance after abdominal surgery. Br J Surg 1994; 81: 5963.
  • 137
    Kim SH, Liu TC, Abbasi F et al. Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg 2009; 19: 15501556.
  • 138
    Kim SH, Abbasi F, Lamendola C, Reaven GM, McLaughlin T. Glucose-stimulated insulin secretion in gastric bypass patients with hypoglycemic syndrome: no evidence for inappropriate pancreatic beta-cell function. Obes Surg 2010; 20: 11101116.
  • 139
    Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 2003; 20: 127134.